Assessing the Intricacies of Deal-Related IP Valuation

November 10, 2020 11:00am

Ahmed Mousa
SVP Corporate Operations & General Counsel
Pieris Pharmaceuticals(Boston, MA)

Laura Wine
Senior IP Counsel
Arena Pharmaceuticals, Inc.

Valuation of life sciences IP is a highly complex and important undertaking as it is often the real driving force behind a given transaction. The valuation process has evolved overtime and several analytical tools have been developed to assist in the valuation process. Topics to be discussed include:

  • Assessing valuation trends, the perceived value of intellectual property and the prices being paid»Understanding the influence of international markets relative to price
  • Incorporating a valuation calculation into your life sciences diligence review
  • Assessing valuation models and adjusting for value drivers such as: regulatory exclusivities, pending legislation, follow-on development, and competing IP•Considering criteria that can impact the overall value of the deal
  • Working with experts in niche fields in connection with valuation